167 related articles for article (PubMed ID: 1723633)
1. The alpha-galactosyl epitope on human normal and autoimmune thyroid cells.
Thall A; Etienne-Decerf J; Winand RJ; Galili U
Autoimmunity; 1991; 10(2):81-7. PubMed ID: 1723633
[TBL] [Abstract][Full Text] [Related]
2. Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.
Galili U
Springer Semin Immunopathol; 1993; 15(2-3):155-71. PubMed ID: 7504839
[TBL] [Abstract][Full Text] [Related]
3. The alpha-galactosyl epitope on mammalian thyroid cells.
Thall A; Etienne-Decerf J; Winand RJ; Galili U
Acta Endocrinol (Copenh); 1991 Jun; 124(6):692-9. PubMed ID: 1712528
[TBL] [Abstract][Full Text] [Related]
4. Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.
Galili U; Shohet SB; Kobrin E; Stults CL; Macher BA
J Biol Chem; 1988 Nov; 263(33):17755-62. PubMed ID: 2460463
[TBL] [Abstract][Full Text] [Related]
5. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes?
Galili U
Lancet; 1989 Aug; 2(8659):358-61. PubMed ID: 2474731
[TBL] [Abstract][Full Text] [Related]
7. Specific stimulation of Graves' disease thyrocytes by the natural anti-Gal antibody from normal and autologous serum.
Winand RJ; Devigne JW; Meurisse M; Galili U
J Immunol; 1994 Aug; 153(3):1386-95. PubMed ID: 8027563
[TBL] [Abstract][Full Text] [Related]
8. Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model.
Repik PM; Strizki JM; Galili U
J Gen Virol; 1994 May; 75 ( Pt 5)():1177-81. PubMed ID: 7513744
[TBL] [Abstract][Full Text] [Related]
9. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of alpha-galactosyl epitopes by recombinant alpha1,3galactosyl transferase for opsonization of human tumor cell vaccines by anti-galactose.
LaTemple DC; Henion TR; Anaraki F; Galili U
Cancer Res; 1996 Jul; 56(13):3069-74. PubMed ID: 8674064
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Gal alpha 1----3Gal beta 1----4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay.
Thall A; Galili U
Biochemistry; 1990 Apr; 29(16):3959-65. PubMed ID: 2354167
[TBL] [Abstract][Full Text] [Related]
12. Evolutionary relationship between the natural anti-Gal antibody and the Gal alpha 1----3Gal epitope in primates.
Galili U; Clark MR; Shohet SB; Buehler J; Macher BA
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1369-73. PubMed ID: 2434954
[TBL] [Abstract][Full Text] [Related]
13. alpha-galactosyl (Galalpha1-3Galbeta1-4GlcNAc-R) epitopes on human cells: synthesis of the epitope on human red cells by recombinant primate alpha1,3galactosyltransferase expressed in E.coli.
Galili U; Anaraki F
Glycobiology; 1995 Dec; 5(8):775-82. PubMed ID: 8720075
[TBL] [Abstract][Full Text] [Related]
14. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
Galili U
Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
[TBL] [Abstract][Full Text] [Related]
15. Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.
Galili U; Tibell A; Samuelsson B; Rydberg L; Groth CG
Transplantation; 1995 Jun; 59(11):1549-56. PubMed ID: 7539957
[TBL] [Abstract][Full Text] [Related]
16. Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations.
Wang L; Radic MZ; Galili U
J Immunol; 1995 Aug; 155(3):1276-85. PubMed ID: 7543518
[TBL] [Abstract][Full Text] [Related]
17. Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora.
Galili U; Mandrell RE; Hamadeh RM; Shohet SB; Griffiss JM
Infect Immun; 1988 Jul; 56(7):1730-7. PubMed ID: 3290105
[TBL] [Abstract][Full Text] [Related]
18. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.
Rother RP; Fodor WL; Springhorn JP; Birks CW; Setter E; Sandrin MS; Squinto SP; Rollins SA
J Exp Med; 1995 Nov; 182(5):1345-55. PubMed ID: 7595205
[TBL] [Abstract][Full Text] [Related]
19. Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies.
Thibaudeau K; Borche L; Soulillou JP; Blanchard D
Blood; 1996 Jun; 87(11):4636-42. PubMed ID: 8639832
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of circulating autoantibodies against the plasma membrane of isolated thyroid cells in Graves' disease.
Hopf U; Fiek T; Grün R; Zuschneid W
J Clin Lab Immunol; 1982 Oct; 9(1):49-53. PubMed ID: 6757440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]